Direct vasoconstrictor effect of prostaglandin E2 on renal interlobular arteries:: role of the EP3 receptor

被引:30
|
作者
van Rodijnen, William F.
Korstjens, Iolente J.
Legerstee, Natalee
ter Wee, Piet M.
Tangelder, Geert-Jan
机构
[1] Free Univ Amsterdam, Cardiovasc Res Inst, Physiol Lab, Med Ctr, NL-1081 BT Amsterdam, Netherlands
[2] Free Univ Amsterdam, Dept Nephrol, Cardiovasc Res Inst, Med Ctr, NL-1081 BT Amsterdam, Netherlands
关键词
interlobular arteries; vasoconstriction;
D O I
10.1152/ajprenal.00351.2005
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
Evidence indicates that prostaglandin E-2 ( PGE(2)) preferentially affects preglomerular renal vessels. However, whether this is limited to small-caliber arterioles or whether larger vessels farther upstream also respond to PGE(2) is currently unclear. In the present study, we first investigated the effects of PGE(2) along the preglomerular vascular tree and subsequently focused on proximal interlobular arteries ( ILAs). Proximal ILAs in hydronephrotic rat kidneys as well as isolated vessels from normal kidneys constricted in response to PGE(2), both under basal conditions and after the induction of vascular tone. By contrast, smaller vessels, i. e., distal ILAs and afferent arterioles, exhibited PGE(2)-induced vasodilation. Endothelium removal and pretreatment of single, isolated proximal ILAs with an EP1 receptor blocker ( SC51322, 1 mu mol/ l) or a thromboxane A(2) receptor blocker ( SQ29548, 1 mu mol/ l) did not prevent vasoconstriction to PGE(2). Furthermore, in the presence of SC51322, responses of these vessels to PGE(2) and the EP1/EP3 agonist sulprostone were superimposable, indicating that PGE(2)-induced vasoconstriction is mediated by EP3 receptors on smooth muscle cells. Immunohistochemical staining of proximal ILAs confirmed the presence of EP3 receptor protein on these cells and the endothelium. Adding PGE(2) to normal isolated kidneys induced a biphasic flow response, i. e., an initial flow increase at PGE(2) concentrations <= 0.1 mu mol/ l followed by a flow decrease at 1 mu mol/ l PGE(2). Thus our results demonstrate that PGE(2) affects multiple segments of the preglomerular vascular tree in a different way. At the level of the proximal ILAs, PGE(2) had a direct vasoconstrictor action mediated by EP3 receptors.
引用
收藏
页码:F1094 / F1101
页数:8
相关论文
共 50 条
  • [41] Urinary concentrating function in mice lacking EP3 receptors for prostaglandin E2
    Fleming, EF
    Athirakul, K
    Oliverio, MI
    Key, M
    Goulet, J
    Koller, BH
    Coffman, TM
    AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 1998, 275 (06) : F955 - F961
  • [42] Constitutive activity of prostaglandin E receptor EP3 isoforms
    Jin, JG
    Mao, GF
    Ashby, B
    THROMBOSIS AND HAEMOSTASIS, 1997, : P2726 - P2726
  • [43] In vitro response of prostaglandin E2 receptor (EP3) in the term pregnant rat uterus and cervix to misoprostol
    Lyons, C
    Beharry, K
    Akmal, Y
    Attenello, F
    Nageotte, MP
    PROSTAGLANDINS & OTHER LIPID MEDIATORS, 2003, 70 (3-4): : 317 - 329
  • [44] Overexpression of the Prostaglandin E2 EP3 Receptor Reduces Cardiac Function in an Angiotensin II Model of Hypertension
    Bryson, Timothy D.
    Xu, Jiang
    Taube, David
    Peterson, Edward
    Harding, Pamela
    CIRCULATION RESEARCH, 2019, 125
  • [45] Prostaglandin E2 enhances neurotrophin-4 production via EP3 receptor in human keratinocytes
    Kanda, N
    Koike, S
    Watanabe, S
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2005, 315 (02): : 796 - 804
  • [46] Prostaglandin E2 receptor EP3 regulates both adipogenesis and lipolysis in mouse white adipose tissue
    Xu, Hu
    Fu, Jia-Lin
    Miao, Yi-Fei
    Wang, Chun-Jiong
    Han, Qi-Fei
    Li, Sha
    Huang, Shi-Zheng
    Du, Sheng-Nan
    Qiu, Yu-Xiang
    Yang, Ji-Chun
    Gustafsson, Jan-Ake
    Breyer, Richard M.
    Zheng, Feng
    Wang, Nan-Ping
    Zhang, Xiao-Yan
    Guan, You-Fei
    JOURNAL OF MOLECULAR CELL BIOLOGY, 2016, 8 (06) : 518 - 529
  • [47] Identification and functional characterization of prostaglandin E2 receptor EP3 subtype in PC12 cells.
    Matsuoka, I
    Ono, T
    Ohkubo, S
    Nakanishi, H
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1998, 358 (01) : R722 - R722
  • [48] DG-041, a novel antiplatelet agent, is a potent and selective antagonist of the EP3 receptor for prostaglandin E2
    Singh, Jasbir
    Andresson, Thorkell
    Ramirez, Jose
    Zeller, Wayne
    Gurney, Mark
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2007, 27 (06) : E80 - E80
  • [49] The role of E-type prostaglandin receptor EP3 in acute renal injury induced by ischemia-reperfusion
    Jing, Leng
    Wen, Zhao
    Bin, Liu
    JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2020, 140 : 56 - 56
  • [50] Expression of the prostaglandin E2 receptors EP1, EP2, EP3 and EP4 in human kidney
    Morath, R
    Klein, T
    Seyberth, HW
    Nüsing, RM
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1998, 358 (01) : R725 - R725